Wordt geladen...
Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
BACKGROUND: Data on safety and efficacy of voriconazole for invasive aspergillosis (IA) and invasive candidiasis/esophageal candidiasis (IC/EC) in pediatric patients are limited. METHODS: Patients aged 2–<18 years with IA and IC/EC were enrolled in 2 prospective open-label, non-comparative studie...
Bewaard in:
| Gepubliceerd in: | Pediatr Infect Dis J |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Williams & Wilkins
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5345593/ https://ncbi.nlm.nih.gov/pubmed/27636722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001339 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|